Literature DB >> 23991404

Diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus.

Jae-Seung Yun1, Seung-Hyun Ko, Ji-Hoon Kim, Keon-Woong Moon, Kun-Woong Moon, Yong-Moon Park, Ki-Dong Yoo, Yu-Bae Ahn.   

Abstract

BACKGROUND: We investigated the relationship between endothelial dysfunction and diabetic retinopathy (DR) in patients with type 2 diabetes.
METHODS: We used a cross-sectional design to examine 167 patients with type 2 diabetes mellitus. All patients underwent biochemical and ophthalmological examination. We assessed endothelial dysfunction by a flow-mediated vasodilation method of the brachial artery. Changes in vasodilation (flow-mediated vasodilatation, %FMD) were expressed as percent change over baseline values.
RESULTS: The mean±standard deviation of patient age was 54.1±8.6 years. The %FMD was significantly lower in patients with DR than without DR. The prevalence of retinopathy decreased across increasing tertiles of %FMD. After adjusting for patients' age, sex, diabetes duration, use of insulin, use of antihypertensive, antiplatelet, and lipid lowering medications, systolic blood pressure, fasting plasma glucose, 2-hour plasma glucose, glycated hemoglobin, and urinary albumin excretion, participants with a reduced %FMD were more likely to have DR (odds ratio, 11.819; 95% confidence interval, 2.201 to 63.461; P=0.004, comparing the lowest and highest tertiles of %FMD).
CONCLUSION: Endothelial dysfunction was associated with DR, which was most apparent when the endothelial dysfunction was severe. Our study provides insights into the possible mechanism of the influence of endothelial dysfunction on the development of DR.

Entities:  

Keywords:  Diabetes mellitus, type 2; Diabetic retinopathy; Endothelial dysfunction; Flow-mediated vasodilation

Year:  2013        PMID: 23991404      PMCID: PMC3753491          DOI: 10.4093/dmj.2013.37.4.262

Source DB:  PubMed          Journal:  Diabetes Metab J        ISSN: 2233-6079            Impact factor:   5.376


  37 in total

1.  Association between diabetic retinopathy and flow-mediated vasodilation in type 2 DM.

Authors:  Kenji Sogawa; Taiji Nagaoka; Ichiro Tanano; Tomofumi Tani; Tsuneaki Omae; Seigo Nakabayashi; Akihiro Ishibazawa; Atsushi Takahashi; Akitoshi Yoshida
Journal:  Curr Eye Res       Date:  2012-05       Impact factor: 2.424

Review 2.  Non-invasive diagnostic tools for investigating endothelial dysfunction.

Authors:  Lorenzo Ghiadoni; Daniele Versari; Chiara Giannarelli; Francesco Faita; Stefano Taddei
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

3.  Diabetic retinopathy.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

4.  Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

Authors:  M A Creager; J P Cooke; M E Mendelsohn; S J Gallagher; S M Coleman; J Loscalzo; V J Dzau
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

5.  Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease.

Authors:  T Neunteufl; R Katzenschlager; A Hassan; U Klaar; S Schwarzacher; D Glogar; P Bauer; F Weidinger
Journal:  Atherosclerosis       Date:  1997-02-28       Impact factor: 5.162

6.  Association between insulin resistance and endothelial dysfunction in type 2 diabetes and the effects of pioglitazone.

Authors:  Masaaki Suzuki; Itaru Takamisawa; Yasunao Yoshimasa; Yutaka Harano
Journal:  Diabetes Res Clin Pract       Date:  2006-09-27       Impact factor: 5.602

7.  Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.

Authors:  A E Caballero; S Arora; R Saouaf; S C Lim; P Smakowski; J Y Park; G L King; F W LoGerfo; E S Horton; A Veves
Journal:  Diabetes       Date:  1999-09       Impact factor: 9.461

8.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

9.  Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.

Authors:  Sandra J Hamilton; Gerard T Chew; Timothy M E Davis; Gerald F Watts
Journal:  Clin Sci (Lond)       Date:  2010-02-23       Impact factor: 6.124

10.  Correlation of flicker-induced and flow-mediated vasodilatation in patients with endothelial dysfunction and healthy volunteers.

Authors:  Berthold Pemp; Günther Weigert; Katharina Karl; Ursula Petzl; Michael Wolzt; Leopold Schmetterer; Gerhard Garhofer
Journal:  Diabetes Care       Date:  2009-05-28       Impact factor: 17.152

View more
  11 in total

1.  The joint effect of the endothelin receptor B gene (EDNRB) polymorphism rs10507875 and nitric oxide synthase 3 gene (NOS3) polymorphism rs869109213 in Slovenian patients with type 2 diabetes mellitus and diabetic retinopathy.

Authors:  Dejan Bregar; Ines Cilenšek; Sara Mankoč; Ana Reschner; Danijel Petrovič; Mojca Globočnik Petrovič
Journal:  Bosn J Basic Med Sci       Date:  2018-02-20       Impact factor: 3.363

Review 2.  The role of microRNAs in the healing of diabetic ulcers.

Authors:  Golnaz Goodarzi; Mahmood Maniati; Durdi Qujeq
Journal:  Int Wound J       Date:  2019-02-28       Impact factor: 3.315

Review 3.  Micro (mi) RNA and Diabetic Retinopathy.

Authors:  Praveen Sharma; Shailendra Dwivedi; Sunita Tiwari; Pankaj Kumar Singh; Amit Pal; Sandeep Kumar
Journal:  Indian J Clin Biochem       Date:  2022-01-14

4.  Vitreous microparticles contain apoptotic signals suggesting a diabetic vitreopathy.

Authors:  Harris Sultan; Rithwick Rajagopal; Prabakar Kumar Rao; Kisha Deslee Piggott; Michael A Paley; Lynn Marisa Hassman; Albert S Li; Brigid Marshall; Rajendra Shridhar Apte
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.645

5.  Flow Mediated Dilatation Is Reduced with the Progressive Stages of Glomerular Filtration Rate and Albuminuria in Type 2 Diabetic Patients without Coronary Heart Disease.

Authors:  Hiroyuki Ito; Mina Nakashima; Kentaro Meguro; Haruki Furukawa; Hitomi Yamashita; Akifusa Takaki; Chizuko Yukawa; Takashi Omoto; Masahiro Shinozaki; Shinya Nishio; Mariko Abe; Shinichi Antoku; Mizuo Mifune; Michiko Togane
Journal:  J Diabetes Res       Date:  2015-04-29       Impact factor: 4.011

Review 6.  The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound Healing.

Authors:  João Moura; Elisabet Børsheim; Eugenia Carvalho
Journal:  Genes (Basel)       Date:  2014-09-29       Impact factor: 4.096

7.  Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea.

Authors:  Jae Seung Yun; Tae Seok Lim; Seon Ah Cha; Yu Bae Ahn; Ki Ho Song; Jin A Choi; Jinwoo Kwon; Donghyun Jee; Yang Kyung Cho; Yong Moon Park; Seung Hyun Ko
Journal:  Diabetes Metab J       Date:  2016-10-05       Impact factor: 5.376

Review 8.  Ethnomedicinal Value of Antidiabetic Plants in Bangladesh: A Comprehensive Review.

Authors:  Md Masudur Rahman; Md Josim Uddin; A S M Ali Reza; Abu Montakim Tareq; Talha Bin Emran; Jesus Simal-Gandara
Journal:  Plants (Basel)       Date:  2021-04-08

9.  Relating Retinal Vascular Oxygen Saturation and Microvasculature Morphology at Progressive Stages of Diabetic Retinopathy.

Authors:  Selin L Auvazian; Jennifer Cano; Sophie Leahy; Preny Karamian; Amir Kashani; Andrew Moshfeghi; Hossein Ameri; Norman P Blair; Mahnaz Shahidi
Journal:  Transl Vis Sci Technol       Date:  2021-05-03       Impact factor: 3.283

10.  Letter: diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus (diabetes metab j 2013;37:262-9).

Authors:  Seok Man Son
Journal:  Diabetes Metab J       Date:  2013-10       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.